date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.477137395905592.
The log-likelihood improved by 4.421.
Iteration 2 of at most 500:
Optimizing with step length 0.615666357266335.
The log-likelihood improved by 2.438.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.565.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.5802.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       2       24     1172     1004      805      370      386      385 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     290      206      168       92       45       26       15        4 
degree16 degree19 
       5        1 
1 
disease_progression 
H-positive risk:  858 850 116 842 433 128 885 489 142 62 135 60 
H-negative risk:  850 858 885 842 489 433 128 116 135 142 60 62 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
64 new agents 
2 
disease_progression 
H-positive risk:  866 859 118 839 428 128 877 489 140 60 134 62 
H-negative risk:  859 866 877 839 489 428 128 118 134 140 62 60 
New BC onsets:  2
BC status:  4998 2 
BC subtype:  4998 2 

clinical_engagement 
diagnosis 
demography 
55 new agents 
3 
disease_progression 
H-positive risk:  869 871 119 837 417 126 872 489 140 60 135 65 
H-negative risk:  871 869 872 837 489 417 126 119 135 140 65 60 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 3 

clinical_engagement 
diagnosis 
demography 
58 new agents 
4 
disease_progression 
H-positive risk:  870 867 123 836 415 129 870 489 141 59 137 64 
H-negative risk:  867 870 870 836 489 415 129 123 137 141 64 59 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 6 

clinical_engagement 
diagnosis 
demography 
58 new agents 
5 
disease_progression 
H-positive risk:  876 872 120 832 415 131 867 484 141 61 136 65 
H-negative risk:  872 876 867 832 484 415 131 120 136 141 65 61 
New BC onsets:  8
BC status:  4992 8 
BC subtype:  4992 8 

clinical_engagement 
diagnosis 
demography 
55 new agents 
6 
disease_progression 
H-positive risk:  888 870 122 829 415 131 862 480 140 62 135 66 
H-negative risk:  870 888 862 829 480 415 131 122 135 140 66 62 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 11 

clinical_engagement 
diagnosis 
demography 
68 new agents 
7 
disease_progression 
H-positive risk:  888 881 122 832 409 132 865 475 140 61 131 64 
H-negative risk:  881 888 865 832 475 409 132 122 131 140 64 61 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 11 

clinical_engagement 
diagnosis 
demography 
63 new agents 
8 
disease_progression 
H-positive risk:  891 877 122 828 411 134 871 473 140 60 130 63 
H-negative risk:  877 891 871 828 473 411 134 122 130 140 63 60 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 13 

clinical_engagement 
diagnosis 
demography 
74 new agents 
9 
disease_progression 
H-positive risk:  898 881 123 826 404 137 869 468 139 61 129 65 
H-negative risk:  881 898 869 826 468 404 137 123 129 139 65 61 
New BC onsets:  15
BC status:  4985 15 
BC subtype:  4985 15 

clinical_engagement 
diagnosis 
demography 
66 new agents 
10 
disease_progression 
H-positive risk:  903 888 124 828 400 137 868 460 140 61 130 61 
H-negative risk:  888 903 868 828 460 400 137 124 130 140 61 61 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 16 1 

clinical_engagement 
diagnosis 
demography 
55 new agents 
11 
disease_progression 
H-positive risk:  909 897 125 831 400 137 862 452 138 61 128 60 
H-negative risk:  897 909 862 831 452 400 137 125 128 138 60 61 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 17 1 

clinical_engagement 
diagnosis 
demography 
61 new agents 
12 
disease_progression 
H-positive risk:  913 901 126 834 396 137 854 450 140 62 127 60 
H-negative risk:  901 913 854 834 450 396 137 126 127 140 60 62 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 21 1 

clinical_engagement 
diagnosis 
demography 
45 new agents 
13 
disease_progression 
H-positive risk:  831 841 117 896 394 120 942 445 156 61 139 58 
H-negative risk:  841 831 942 896 445 394 120 117 139 156 58 61 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 23 1 

clinical_engagement 
diagnosis 
demography 
202 new agents 
14 
disease_progression 
H-positive risk:  850 874 117 855 414 127 904 458 148 64 121 68 
H-negative risk:  874 850 904 855 458 414 127 117 121 148 68 64 
New BC onsets:  28
BC status:  4972 28 
BC subtype:  4972 24 4 

clinical_engagement 
diagnosis 
demography 
73 new agents 
15 
disease_progression 
H-positive risk:  857 877 121 857 411 128 906 448 149 64 116 66 
H-negative risk:  877 857 906 857 448 411 128 121 116 149 66 64 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 27 4 

clinical_engagement 
diagnosis 
demography 
69 new agents 
16 
disease_progression 
H-positive risk:  856 880 123 862 413 127 901 438 153 63 117 67 
H-negative risk:  880 856 901 862 438 413 127 123 117 153 67 63 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 28 4 

clinical_engagement 
diagnosis 
demography 
62 new agents 
17 
disease_progression 
H-positive risk:  855 884 124 858 415 129 913 422 155 63 116 66 
H-negative risk:  884 855 913 858 422 415 129 124 116 155 66 63 
New BC onsets:  33
BC status:  4967 33 
BC subtype:  4967 29 4 

clinical_engagement 
diagnosis 
demography 
78 new agents 
18 
disease_progression 
H-positive risk:  854 886 126 856 407 128 922 422 155 63 116 65 
H-negative risk:  886 854 922 856 422 407 128 126 116 155 65 63 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 28 4 

clinical_engagement 
diagnosis 
demography 
48 new agents 
19 
disease_progression 
H-positive risk:  853 893 128 858 410 128 917 417 154 62 114 66 
H-negative risk:  893 853 917 858 417 410 128 128 114 154 66 62 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 27 5 

clinical_engagement 
diagnosis 
demography 
48 new agents 
20 
disease_progression 
H-positive risk:  862 900 128 851 401 131 915 418 152 63 115 64 
H-negative risk:  900 862 915 851 418 401 131 128 115 152 64 63 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 31 4 

clinical_engagement 
diagnosis 
demography 
68 new agents 
21 
disease_progression 
H-positive risk:  865 906 132 850 396 133 914 409 154 63 116 62 
H-negative risk:  906 865 914 850 409 396 133 132 116 154 62 63 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 32 5 

clinical_engagement 
diagnosis 
demography 
64 new agents 
22 
disease_progression 
H-positive risk:  873 907 132 851 393 132 911 407 153 63 116 62 
H-negative risk:  907 873 911 851 407 393 132 132 116 153 62 63 
New BC onsets:  41
BC status:  4959 41 
BC subtype:  4959 36 5 

clinical_engagement 
diagnosis 
demography 
65 new agents 
23 
disease_progression 
H-positive risk:  881 905 131 847 388 133 917 407 152 64 116 59 
H-negative risk:  905 881 917 847 407 388 133 131 116 152 59 64 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 37 5 

clinical_engagement 
diagnosis 
demography 
61 new agents 
24 
disease_progression 
H-positive risk:  887 913 130 841 386 132 917 403 153 65 113 60 
H-negative risk:  913 887 917 841 403 386 132 130 113 153 60 65 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 39 5 

clinical_engagement 
diagnosis 
demography 
60 new agents 
25 
disease_progression 
H-positive risk:  814 835 119 924 387 117 991 402 164 65 123 59 
H-negative risk:  835 814 991 924 402 387 117 119 123 164 59 65 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 41 5 

clinical_engagement 
diagnosis 
demography 
173 new agents 
26 
disease_progression 
H-positive risk:  839 850 122 880 419 120 957 410 161 66 118 58 
H-negative risk:  850 839 957 880 410 419 120 122 118 161 58 66 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 44 5 

clinical_engagement 
diagnosis 
demography 
76 new agents 
27 
disease_progression 
H-positive risk:  844 857 123 886 412 120 957 401 161 66 117 56 
H-negative risk:  857 844 957 886 401 412 120 123 117 161 56 66 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 46 7 

clinical_engagement 
diagnosis 
demography 
74 new agents 
28 
disease_progression 
H-positive risk:  848 864 125 881 410 118 957 398 163 66 116 54 
H-negative risk:  864 848 957 881 398 410 118 125 116 163 54 66 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 47 8 

clinical_engagement 
diagnosis 
demography 
63 new agents 
29 
disease_progression 
H-positive risk:  849 862 126 878 409 117 968 396 161 67 116 51 
H-negative risk:  862 849 968 878 396 409 117 126 116 161 51 67 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 49 8 

clinical_engagement 
diagnosis 
demography 
63 new agents 
30 
disease_progression 
H-positive risk:  850 867 125 879 413 117 964 390 160 66 117 52 
H-negative risk:  867 850 964 879 390 413 117 125 117 160 52 66 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 47 11 

clinical_engagement 
diagnosis 
demography 
66 new agents 
31 
disease_progression 
H-positive risk:  856 872 125 880 412 117 958 389 159 66 115 51 
H-negative risk:  872 856 958 880 389 412 117 125 115 159 51 66 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 48 10 

clinical_engagement 
diagnosis 
demography 
61 new agents 
32 
disease_progression 
H-positive risk:  857 876 122 880 407 115 963 390 159 64 116 51 
H-negative risk:  876 857 963 880 390 407 115 122 116 159 51 64 
New BC onsets:  56
BC status:  4944 56 
BC subtype:  4944 46 10 

clinical_engagement 
diagnosis 
demography 
52 new agents 
33 
disease_progression 
H-positive risk:  857 878 120 880 401 117 969 387 158 65 116 52 
H-negative risk:  878 857 969 880 387 401 117 120 116 158 52 65 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 45 10 

clinical_engagement 
diagnosis 
demography 
63 new agents 
34 
disease_progression 
H-positive risk:  853 879 118 882 397 119 972 389 160 62 117 52 
H-negative risk:  879 853 972 882 389 397 119 118 117 160 52 62 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 46 12 

clinical_engagement 
diagnosis 
demography 
81 new agents 
35 
disease_progression 
H-positive risk:  865 879 118 888 389 119 973 380 157 63 117 52 
H-negative risk:  879 865 973 888 380 389 119 118 117 157 52 63 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 49 11 

clinical_engagement 
diagnosis 
demography 
53 new agents 
36 
disease_progression 
H-positive risk:  870 879 118 890 389 120 968 378 156 64 115 53 
H-negative risk:  879 870 968 890 378 389 120 118 115 156 53 64 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 51 11 

clinical_engagement 
diagnosis 
demography 
68 new agents 
37 
disease_progression 
H-positive risk:  818 816 112 944 390 111 1033 375 165 61 126 49 
H-negative risk:  816 818 1033 944 375 390 111 112 126 165 49 61 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 53 12 

clinical_engagement 
diagnosis 
demography 
163 new agents 
38 
disease_progression 
H-positive risk:  830 837 115 916 392 115 1004 396 159 65 125 46 
H-negative risk:  837 830 1004 916 396 392 115 115 125 159 46 65 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 58 13 

clinical_engagement 
diagnosis 
demography 
80 new agents 
39 
disease_progression 
H-positive risk:  837 840 115 909 391 113 1004 399 158 63 128 43 
H-negative risk:  840 837 1004 909 399 391 113 115 128 158 43 63 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 59 13 

clinical_engagement 
diagnosis 
demography 
65 new agents 
40 
disease_progression 
H-positive risk:  838 838 117 914 390 113 1007 395 155 63 128 42 
H-negative risk:  838 838 1007 914 395 390 113 117 128 155 42 63 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 59 13 

clinical_engagement 
diagnosis 
demography 
56 new agents 
41 
disease_progression 
H-positive risk:  839 837 120 925 384 113 995 399 153 64 129 42 
H-negative risk:  837 839 995 925 399 384 113 120 129 153 42 64 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 63 13 

clinical_engagement 
diagnosis 
demography 
54 new agents 
42 
disease_progression 
H-positive risk:  845 838 121 924 375 112 995 397 156 65 129 43 
H-negative risk:  838 845 995 924 397 375 112 121 129 156 43 65 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 65 13 

clinical_engagement 
diagnosis 
demography 
61 new agents 
43 
disease_progression 
H-positive risk:  846 842 121 928 365 111 1004 395 157 62 128 41 
H-negative risk:  842 846 1004 928 395 365 111 121 128 157 41 62 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 64 13 

clinical_engagement 
diagnosis 
demography 
59 new agents 
44 
disease_progression 
H-positive risk:  848 848 119 927 359 112 1003 393 159 62 129 41 
H-negative risk:  848 848 1003 927 393 359 112 119 129 159 41 62 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 65 14 

clinical_engagement 
diagnosis 
demography 
63 new agents 
45 
disease_progression 
H-positive risk:  844 850 121 925 362 112 1002 390 166 61 125 42 
H-negative risk:  850 844 1002 925 390 362 112 121 125 166 42 61 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 64 14 

clinical_engagement 
diagnosis 
demography 
70 new agents 
46 
disease_progression 
H-positive risk:  845 852 122 930 359 112 997 392 163 61 126 41 
H-negative risk:  852 845 997 930 392 359 112 122 126 163 41 61 
New BC onsets:  77
BC status:  4923 77 
BC subtype:  4923 62 15 

clinical_engagement 
diagnosis 
demography 
62 new agents 
47 
disease_progression 
H-positive risk:  840 862 122 923 358 114 998 396 163 55 127 42 
H-negative risk:  862 840 998 923 396 358 114 122 127 163 42 55 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 65 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
48 
disease_progression 
H-positive risk:  833 871 123 919 359 115 998 395 162 55 127 43 
H-negative risk:  871 833 998 919 395 359 115 123 127 162 43 55 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 66 15 

clinical_engagement 
diagnosis 
demography 
56 new agents 
49 
disease_progression 
H-positive risk:  786 815 113 977 355 108 1058 391 168 52 135 42 
H-negative risk:  815 786 1058 977 391 355 108 113 135 168 42 52 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 70 15 

clinical_engagement 
diagnosis 
demography 
141 new agents 
50 
disease_progression 
H-positive risk:  796 822 113 958 357 108 1035 415 161 54 132 49 
H-negative risk:  822 796 1035 958 415 357 108 113 132 161 49 54 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 67 15 

clinical_engagement 
diagnosis 
demography 
79 new agents 
51 
disease_progression 
H-positive risk:  800 822 112 965 360 107 1034 408 164 49 131 48 
H-negative risk:  822 800 1034 965 408 360 107 112 131 164 48 49 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 66 16 

clinical_engagement 
diagnosis 
demography 
64 new agents 
52 
disease_progression 
H-positive risk:  806 822 112 960 358 107 1043 405 161 48 130 48 
H-negative risk:  822 806 1043 960 405 358 107 112 130 161 48 48 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 66 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
53 
disease_progression 
H-positive risk:  811 823 115 961 354 109 1046 400 158 46 129 48 
H-negative risk:  823 811 1046 961 400 354 109 115 129 158 48 46 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 70 17 

clinical_engagement 
diagnosis 
demography 
55 new agents 
54 
disease_progression 
H-positive risk:  811 827 117 964 348 109 1045 398 159 47 129 46 
H-negative risk:  827 811 1045 964 398 348 109 117 129 159 46 47 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 70 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
55 
disease_progression 
H-positive risk:  813 835 116 961 342 111 1051 397 154 44 130 46 
H-negative risk:  835 813 1051 961 397 342 111 116 130 154 46 44 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 69 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
56 
disease_progression 
H-positive risk:  821 842 118 964 340 112 1043 389 149 44 133 45 
H-negative risk:  842 821 1043 964 389 340 112 118 133 149 45 44 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 69 20 

clinical_engagement 
diagnosis 
demography 
50 new agents 
57 
disease_progression 
H-positive risk:  824 834 117 970 340 111 1041 387 149 47 135 45 
H-negative risk:  834 824 1041 970 387 340 111 117 135 149 45 47 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
58 
disease_progression 
H-positive risk:  829 833 114 963 342 110 1043 390 147 51 133 45 
H-negative risk:  833 829 1043 963 390 342 110 114 133 147 45 51 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
57 new agents 
59 
disease_progression 
H-positive risk:  831 831 114 969 341 109 1034 395 146 50 135 45 
H-negative risk:  831 831 1034 969 395 341 109 114 135 146 45 50 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 71 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
60 
disease_progression 
H-positive risk:  831 830 112 967 342 110 1028 404 147 50 135 44 
H-negative risk:  830 831 1028 967 404 342 110 112 135 147 44 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
61 
disease_progression 
H-positive risk:  777 779 101 1010 346 106 1086 404 158 49 141 43 
H-negative risk:  779 777 1086 1010 404 346 106 101 141 158 43 49 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
123 new agents 
62 
disease_progression 
H-positive risk:  783 785 102 986 362 108 1064 417 155 55 139 44 
H-negative risk:  785 783 1064 986 417 362 108 102 139 155 44 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
95 new agents 
63 
disease_progression 
H-positive risk:  788 785 105 971 365 110 1070 410 153 59 137 47 
H-negative risk:  785 788 1070 971 410 365 110 105 137 153 47 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
60 new agents 
64 
disease_progression 
H-positive risk:  783 789 104 982 358 112 1073 410 152 58 135 44 
H-negative risk:  789 783 1073 982 410 358 112 104 135 152 44 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
50 new agents 
65 
disease_progression 
H-positive risk:  788 788 103 983 358 110 1063 413 154 60 134 46 
H-negative risk:  788 788 1063 983 413 358 110 103 134 154 46 60 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
66 
disease_progression 
H-positive risk:  790 794 103 974 362 109 1062 416 154 56 135 45 
H-negative risk:  794 790 1062 974 416 362 109 103 135 154 45 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
61 new agents 
67 
disease_progression 
H-positive risk:  797 796 105 973 357 106 1058 416 156 56 134 46 
H-negative risk:  796 797 1058 973 416 357 106 105 134 156 46 56 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
68 new agents 
68 
disease_progression 
H-positive risk:  800 794 102 977 358 101 1066 410 158 54 135 45 
H-negative risk:  794 800 1066 977 410 358 101 102 135 158 45 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 81 17 

clinical_engagement 
diagnosis 
demography 
62 new agents 
69 
disease_progression 
H-positive risk:  802 800 100 974 360 104 1063 408 153 54 136 46 
H-negative risk:  800 802 1063 974 408 360 104 100 136 153 46 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
60 new agents 
70 
disease_progression 
H-positive risk:  801 803 99 979 363 105 1049 413 152 55 136 45 
H-negative risk:  803 801 1049 979 413 363 105 99 136 152 45 55 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
58 new agents 
71 
disease_progression 
H-positive risk:  795 805 103 981 368 103 1052 409 154 54 131 45 
H-negative risk:  805 795 1052 981 409 368 103 103 131 154 45 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
72 
disease_progression 
H-positive risk:  796 806 105 976 371 104 1053 408 153 54 129 45 
H-negative risk:  806 796 1053 976 408 371 104 105 129 153 45 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 80 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
73 
disease_progression 
H-positive risk:  751 762 96 1035 373 99 1086 407 155 53 138 45 
H-negative risk:  762 751 1086 1035 407 373 99 96 138 155 45 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 76 18 

clinical_engagement 
diagnosis 
demography 
115 new agents 
74 
disease_progression 
H-positive risk:  759 758 96 1015 400 99 1057 430 152 52 135 47 
H-negative risk:  758 759 1057 1015 430 400 99 96 135 152 47 52 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 73 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
75 
disease_progression 
H-positive risk:  758 766 97 1005 408 98 1066 422 149 50 135 46 
H-negative risk:  766 758 1066 1005 422 408 98 97 135 149 46 50 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 72 17 

clinical_engagement 
diagnosis 
demography 
89 new agents 
76 
disease_progression 
H-positive risk:  759 772 96 999 400 97 1075 420 150 51 136 45 
H-negative risk:  772 759 1075 999 420 400 97 96 136 150 45 51 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 71 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
77 
disease_progression 
H-positive risk:  758 768 99 1003 391 102 1078 419 152 49 138 43 
H-negative risk:  768 758 1078 1003 419 391 102 99 138 152 43 49 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
65 new agents 
78 
disease_progression 
H-positive risk:  755 766 100 997 392 100 1086 420 149 51 142 42 
H-negative risk:  766 755 1086 997 420 392 100 100 142 149 42 51 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
79 
disease_progression 
H-positive risk:  761 766 98 996 389 102 1082 421 147 51 143 44 
H-negative risk:  766 761 1082 996 421 389 102 98 143 147 44 51 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
58 new agents 
80 
disease_progression 
H-positive risk:  761 770 96 996 385 104 1080 421 146 52 144 45 
H-negative risk:  770 761 1080 996 421 385 104 96 144 146 45 52 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
81 
disease_progression 
H-positive risk:  766 773 96 990 387 104 1068 427 149 55 143 42 
H-negative risk:  773 766 1068 990 427 387 104 96 143 149 42 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
82 
disease_progression 
H-positive risk:  769 777 96 982 388 105 1066 427 149 54 144 43 
H-negative risk:  777 769 1066 982 427 388 105 96 144 149 43 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
83 
disease_progression 
H-positive risk:  771 779 98 974 386 106 1065 431 147 56 146 41 
H-negative risk:  779 771 1065 974 431 386 106 98 146 147 41 56 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
84 
disease_progression 
H-positive risk:  775 779 98 977 380 106 1068 430 147 53 145 42 
H-negative risk:  779 775 1068 977 430 380 106 98 145 147 42 53 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
85 
disease_progression 
H-positive risk:  731 736 93 1020 386 96 1118 422 154 54 148 42 
H-negative risk:  736 731 1118 1020 422 386 96 93 148 154 42 54 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 68 23 

clinical_engagement 
diagnosis 
demography 
107 new agents 
86 
disease_progression 
H-positive risk:  732 740 91 1006 399 96 1096 439 151 57 149 44 
H-negative risk:  740 732 1096 1006 439 399 96 91 149 151 44 57 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 66 24 

clinical_engagement 
diagnosis 
demography 
91 new agents 
87 
disease_progression 
H-positive risk:  734 745 87 1011 394 95 1094 432 150 59 154 45 
H-negative risk:  745 734 1094 1011 432 394 95 87 154 150 45 59 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 66 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
88 
disease_progression 
H-positive risk:  737 755 87 1013 390 96 1087 427 149 61 152 46 
H-negative risk:  755 737 1087 1013 427 390 96 87 152 149 46 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 68 28 

clinical_engagement 
diagnosis 
demography 
68 new agents 
89 
disease_progression 
H-positive risk:  740 752 88 1016 391 95 1084 426 147 61 151 49 
H-negative risk:  752 740 1084 1016 426 391 95 88 151 147 49 61 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 68 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
90 
disease_progression 
H-positive risk:  734 760 90 1016 390 96 1085 420 147 62 153 47 
H-negative risk:  760 734 1085 1016 420 390 96 90 153 147 47 62 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 67 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
91 
disease_progression 
H-positive risk:  731 757 91 1026 386 95 1089 423 146 58 151 47 
H-negative risk:  757 731 1089 1026 423 386 95 91 151 146 47 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 68 32 

clinical_engagement 
diagnosis 
demography 
73 new agents 
92 
disease_progression 
H-positive risk:  729 765 89 1035 388 95 1078 413 147 61 152 48 
H-negative risk:  765 729 1078 1035 413 388 95 89 152 147 48 61 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 67 32 

clinical_engagement 
diagnosis 
demography 
63 new agents 
93 
disease_progression 
H-positive risk:  733 768 89 1035 382 95 1080 411 149 60 151 47 
H-negative risk:  768 733 1080 1035 411 382 95 89 151 149 47 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 70 32 

clinical_engagement 
diagnosis 
demography 
73 new agents 
94 
disease_progression 
H-positive risk:  731 774 90 1035 381 91 1087 404 149 59 150 49 
H-negative risk:  774 731 1087 1035 404 381 91 90 150 149 49 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
59 new agents 
95 
disease_progression 
H-positive risk:  734 768 93 1044 375 91 1095 396 149 56 151 48 
H-negative risk:  768 734 1095 1044 396 375 91 93 151 149 48 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 72 30 

clinical_engagement 
diagnosis 
demography 
68 new agents 
96 
disease_progression 
H-positive risk:  727 769 95 1049 374 91 1094 399 152 55 148 47 
H-negative risk:  769 727 1094 1049 399 374 91 95 148 152 47 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 71 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
97 
disease_progression 
H-positive risk:  694 717 87 1092 382 86 1127 403 158 56 151 47 
H-negative risk:  717 694 1127 1092 403 382 86 87 151 158 47 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 72 30 

clinical_engagement 
diagnosis 
demography 
94 new agents 
98 
disease_progression 
H-positive risk:  699 722 87 1075 389 91 1122 406 148 63 147 51 
H-negative risk:  722 699 1122 1075 406 389 91 87 147 148 51 63 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 72 29 

clinical_engagement 
diagnosis 
demography 
85 new agents 
99 
disease_progression 
H-positive risk:  704 724 87 1074 385 94 1125 402 147 62 147 49 
H-negative risk:  724 704 1125 1074 402 385 94 87 147 147 49 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
100 
disease_progression 
H-positive risk:  708 728 82 1074 388 98 1114 401 148 62 147 50 
H-negative risk:  728 708 1114 1074 401 388 98 82 147 148 50 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
68 new agents 
101 
disease_progression 
H-positive risk:  708 725 82 1075 386 98 1119 400 149 61 148 49 
H-negative risk:  725 708 1119 1075 400 386 98 82 148 149 49 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 73 28 

clinical_engagement 
diagnosis 
demography 
69 new agents 
102 
disease_progression 
H-positive risk:  716 728 83 1073 382 98 1119 399 146 61 148 47 
H-negative risk:  728 716 1119 1073 399 382 98 83 148 146 47 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 69 28 

clinical_engagement 
diagnosis 
demography 
76 new agents 
103 
disease_progression 
H-positive risk:  719 724 84 1075 375 95 1123 401 150 57 148 49 
H-negative risk:  724 719 1123 1075 401 375 95 84 148 150 49 57 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 68 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
104 
disease_progression 
H-positive risk:  711 728 83 1072 384 93 1131 396 152 53 147 50 
H-negative risk:  728 711 1131 1072 396 384 93 83 147 152 50 53 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 66 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
105 
disease_progression 
H-positive risk:  707 730 80 1069 381 90 1135 399 156 55 149 49 
H-negative risk:  730 707 1135 1069 399 381 90 80 149 156 49 55 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 68 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
106 
disease_progression 
H-positive risk:  714 736 81 1073 369 89 1133 397 157 54 147 50 
H-negative risk:  736 714 1133 1073 397 369 89 81 147 157 50 54 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
107 
disease_progression 
H-positive risk:  721 740 82 1078 362 91 1134 389 154 55 143 51 
H-negative risk:  740 721 1134 1078 389 362 91 82 143 154 51 55 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 67 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
108 
disease_progression 
H-positive risk:  728 732 85 1088 359 90 1123 394 155 53 143 50 
H-negative risk:  732 728 1123 1088 394 359 90 85 143 155 50 53 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 65 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
109 
disease_progression 
H-positive risk:  692 679 84 1133 361 84 1155 402 159 55 145 51 
H-negative risk:  679 692 1155 1133 402 361 84 84 145 159 51 55 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 63 31 

clinical_engagement 
diagnosis 
demography 
107 new agents 
110 
disease_progression 
H-positive risk:  708 682 85 1124 350 86 1136 420 152 63 144 50 
H-negative risk:  682 708 1136 1124 420 350 86 85 144 152 50 63 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 62 30 

clinical_engagement 
diagnosis 
demography 
77 new agents 
111 
disease_progression 
H-positive risk:  714 681 87 1120 343 88 1138 421 153 64 139 52 
H-negative risk:  681 714 1138 1120 421 343 88 87 139 153 52 64 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 60 31 

clinical_engagement 
diagnosis 
demography 
59 new agents 
112 
disease_progression 
H-positive risk:  708 684 88 1121 350 88 1134 421 153 63 140 50 
H-negative risk:  684 708 1134 1121 421 350 88 88 140 153 50 63 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 60 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
113 
disease_progression 
H-positive risk:  703 680 88 1118 356 87 1140 424 154 61 137 52 
H-negative risk:  680 703 1140 1118 424 356 87 88 137 154 52 61 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 60 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
114 
disease_progression 
H-positive risk:  702 686 88 1119 359 86 1142 423 150 57 136 52 
H-negative risk:  686 702 1142 1119 423 359 86 88 136 150 52 57 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 63 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
115 
disease_progression 
H-positive risk:  705 689 88 1120 345 89 1154 413 146 60 140 51 
H-negative risk:  689 705 1154 1120 413 345 89 88 140 146 51 60 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 63 26 

clinical_engagement 
diagnosis 
demography 
71 new agents 
116 
disease_progression 
H-positive risk:  699 696 89 1126 350 89 1157 404 145 60 137 48 
H-negative risk:  696 699 1157 1126 404 350 89 89 137 145 48 60 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 61 25 

clinical_engagement 
diagnosis 
demography 
87 new agents 
117 
disease_progression 
H-positive risk:  702 699 90 1123 349 91 1159 402 148 58 133 46 
H-negative risk:  699 702 1159 1123 402 349 91 90 133 148 46 58 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 59 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
118 
disease_progression 
H-positive risk:  696 699 90 1126 351 94 1152 402 147 57 137 49 
H-negative risk:  699 696 1152 1126 402 351 94 90 137 147 49 57 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 61 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
119 
disease_progression 
H-positive risk:  691 697 90 1132 355 94 1149 403 147 56 136 50 
H-negative risk:  697 691 1149 1132 403 355 94 90 136 147 50 56 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 63 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
120 
disease_progression 
H-positive risk:  684 688 89 1138 361 99 1154 397 146 55 138 51 
H-negative risk:  688 684 1154 1138 397 361 99 89 138 146 51 55 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 64 26 

clinical_engagement 
diagnosis 
demography 
79 new agents 
121 
disease_progression 
H-positive risk:  658 656 82 1182 355 92 1173 398 150 54 148 52 
H-negative risk:  656 658 1173 1182 398 355 92 82 148 150 52 54 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 62 28 

clinical_engagement 
diagnosis 
demography 
103 new agents 
122 
disease_progression 
H-positive risk:  674 648 87 1176 362 91 1152 409 151 52 144 54 
H-negative risk:  648 674 1152 1176 409 362 91 87 144 151 54 52 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 62 28 

clinical_engagement 
diagnosis 
demography 
70 new agents 
123 
disease_progression 
H-positive risk:  672 645 88 1184 365 90 1144 411 151 52 144 54 
H-negative risk:  645 672 1144 1184 411 365 90 88 144 151 54 52 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 63 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
124 
disease_progression 
H-positive risk:  666 653 86 1178 363 94 1148 412 148 53 141 58 
H-negative risk:  653 666 1148 1178 412 363 94 86 141 148 58 53 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 62 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
125 
disease_progression 
H-positive risk:  665 660 85 1181 362 95 1149 411 144 48 142 58 
H-negative risk:  660 665 1149 1181 411 362 95 85 142 144 58 48 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 63 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
126 
disease_progression 
H-positive risk:  660 662 82 1183 370 96 1140 411 146 46 144 60 
H-negative risk:  662 660 1140 1183 411 370 96 82 144 146 60 46 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 63 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
127 
disease_progression 
H-positive risk:  656 660 82 1183 368 95 1149 411 143 46 142 65 
H-negative risk:  660 656 1149 1183 411 368 95 82 142 143 65 46 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 63 26 

clinical_engagement 
diagnosis 
demography 
59 new agents 
128 
disease_progression 
H-positive risk:  652 662 82 1187 362 93 1144 418 142 50 143 65 
H-negative risk:  662 652 1144 1187 418 362 93 82 143 142 65 50 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 66 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
129 
disease_progression 
H-positive risk:  655 667 81 1185 364 93 1141 413 143 51 144 63 
H-negative risk:  667 655 1141 1185 413 364 93 81 144 143 63 51 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 65 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
130 
disease_progression 
H-positive risk:  658 671 82 1180 371 93 1148 402 139 51 142 63 
H-negative risk:  671 658 1148 1180 402 371 93 82 142 139 63 51 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 66 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
131 
disease_progression 
H-positive risk:  667 670 80 1176 367 93 1153 401 139 50 144 60 
H-negative risk:  670 667 1153 1176 401 367 93 80 144 139 60 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
59 new agents 
132 
disease_progression 
H-positive risk:  672 670 78 1168 369 92 1156 401 140 51 143 60 
H-negative risk:  670 672 1156 1168 401 369 92 78 143 140 60 51 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
133 
disease_progression 
H-positive risk:  673 671 78 1166 371 92 1158 396 140 51 144 60 
H-negative risk:  671 673 1158 1166 396 371 92 78 144 140 60 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
111 new agents 
134 
disease_progression 
H-positive risk:  654 673 78 1155 371 94 1178 406 134 52 146 59 
H-negative risk:  673 654 1178 1155 406 371 94 78 146 134 59 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
135 
disease_progression 
H-positive risk:  647 669 77 1161 372 96 1175 411 132 53 146 61 
H-negative risk:  669 647 1175 1161 411 372 96 77 146 132 61 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
66 new agents 
136 
disease_progression 
H-positive risk:  649 670 77 1169 367 95 1169 408 132 55 147 62 
H-negative risk:  670 649 1169 1169 408 367 95 77 147 132 62 55 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
87 new agents 
137 
disease_progression 
H-positive risk:  652 679 74 1164 362 94 1176 403 134 52 149 61 
H-negative risk:  679 652 1176 1164 403 362 94 74 149 134 61 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
94 new agents 
138 
disease_progression 
H-positive risk:  650 672 76 1174 357 95 1173 402 136 53 151 61 
H-negative risk:  672 650 1173 1174 402 357 95 76 151 136 61 53 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
62 new agents 
139 
disease_progression 
H-positive risk:  649 666 75 1178 349 97 1176 407 135 52 153 63 
H-negative risk:  666 649 1176 1178 407 349 97 75 153 135 63 52 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 69 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
140 
disease_progression 
H-positive risk:  651 668 77 1176 349 97 1176 402 136 53 151 64 
H-negative risk:  668 651 1176 1176 402 349 97 77 151 136 64 53 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
141 
disease_progression 
H-positive risk:  659 664 80 1171 357 98 1170 401 137 51 150 62 
H-negative risk:  664 659 1170 1171 401 357 98 80 150 137 62 51 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 68 28 

clinical_engagement 
diagnosis 
demography 
82 new agents 
142 
disease_progression 
H-positive risk:  659 671 83 1160 356 97 1172 403 138 54 148 59 
H-negative risk:  671 659 1172 1160 403 356 97 83 148 138 59 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 66 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
143 
disease_progression 
H-positive risk:  667 675 82 1152 356 96 1172 403 141 49 148 59 
H-negative risk:  675 667 1172 1152 403 356 96 82 148 141 59 49 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 64 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
144 
disease_progression 
H-positive risk:  675 670 85 1152 354 95 1165 406 140 49 147 62 
H-negative risk:  670 675 1165 1152 406 354 95 85 147 140 62 49 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 63 26 

clinical_engagement 
diagnosis 
demography 
63 new agents 
145 
disease_progression 
H-positive risk:  674 679 83 1151 359 98 1160 403 135 49 149 60 
H-negative risk:  679 674 1160 1151 403 359 98 83 149 135 60 49 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 63 27 

clinical_engagement 
diagnosis 
demography 
92 new agents 
146 
disease_progression 
H-positive risk:  675 687 82 1124 372 95 1153 414 137 51 149 61 
H-negative risk:  687 675 1153 1124 414 372 95 82 149 137 61 51 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 60 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
147 
disease_progression 
H-positive risk:  676 690 83 1120 372 91 1156 411 140 50 150 61 
H-negative risk:  690 676 1156 1120 411 372 91 83 150 140 61 50 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 60 27 

clinical_engagement 
diagnosis 
demography 
85 new agents 
148 
disease_progression 
H-positive risk:  679 692 85 1121 372 88 1153 406 143 49 151 61 
H-negative risk:  692 679 1153 1121 406 372 88 85 151 143 61 49 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 59 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
149 
disease_progression 
H-positive risk:  677 693 86 1125 368 88 1153 403 144 48 156 59 
H-negative risk:  693 677 1153 1125 403 368 88 86 156 144 59 48 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 58 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
150 
disease_progression 
H-positive risk:  683 691 87 1125 368 89 1152 406 143 46 149 61 
H-negative risk:  691 683 1152 1125 406 368 89 87 149 143 61 46 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 58 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
151 
disease_progression 
H-positive risk:  679 692 90 1130 370 87 1150 403 145 46 146 62 
H-negative risk:  692 679 1150 1130 403 370 87 90 146 145 62 46 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 62 25 

clinical_engagement 
diagnosis 
demography 
58 new agents 
152 
disease_progression 
H-positive risk:  679 691 92 1131 372 87 1147 404 144 48 143 62 
H-negative risk:  691 679 1147 1131 404 372 87 92 143 144 62 48 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 61 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
153 
disease_progression 
H-positive risk:  682 696 93 1119 377 87 1150 401 143 46 144 62 
H-negative risk:  696 682 1150 1119 401 377 87 93 144 143 62 46 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 61 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
154 
disease_progression 
H-positive risk:  681 696 93 1120 379 85 1154 398 146 44 143 61 
H-negative risk:  696 681 1154 1120 398 379 85 93 143 146 61 44 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 62 26 

clinical_engagement 
diagnosis 
demography 
66 new agents 
155 
disease_progression 
H-positive risk:  682 696 92 1124 379 84 1152 393 149 45 142 62 
H-negative risk:  696 682 1152 1124 393 379 84 92 142 149 62 45 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 66 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
156 
disease_progression 
H-positive risk:  675 703 93 1111 379 84 1155 394 148 50 146 62 
H-negative risk:  703 675 1155 1111 394 379 84 93 146 148 62 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
157 
disease_progression 
H-positive risk:  682 700 93 1114 377 85 1156 390 148 50 143 62 
H-negative risk:  700 682 1156 1114 390 377 85 93 143 148 62 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
90 new agents 
158 
disease_progression 
H-positive risk:  675 701 93 1109 392 84 1145 397 150 51 146 57 
H-negative risk:  701 675 1145 1109 397 392 84 93 146 150 57 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
96 new agents 
159 
disease_progression 
H-positive risk:  672 703 98 1109 383 85 1144 398 152 52 143 61 
H-negative risk:  703 672 1144 1109 398 383 85 98 143 152 61 52 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
160 
disease_progression 
H-positive risk:  673 700 99 1111 382 87 1148 394 152 51 142 61 
H-negative risk:  700 673 1148 1111 394 382 87 99 142 152 61 51 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
161 
disease_progression 
H-positive risk:  669 698 96 1112 380 87 1143 404 155 51 142 63 
H-negative risk:  698 669 1143 1112 404 380 87 96 142 155 63 51 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
162 
disease_progression 
H-positive risk:  679 697 96 1111 376 87 1141 399 155 53 145 61 
H-negative risk:  697 679 1141 1111 399 376 87 96 145 155 61 53 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
163 
disease_progression 
H-positive risk:  674 689 98 1112 380 87 1139 399 157 53 148 64 
H-negative risk:  689 674 1139 1112 399 380 87 98 148 157 64 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
164 
disease_progression 
H-positive risk:  675 684 100 1120 378 89 1138 399 156 54 142 65 
H-negative risk:  684 675 1138 1120 399 378 89 100 142 156 65 54 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 70 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
165 
disease_progression 
H-positive risk:  668 687 99 1114 382 88 1144 395 156 54 147 66 
H-negative risk:  687 668 1144 1114 395 382 88 99 147 156 66 54 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 71 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
166 
disease_progression 
H-positive risk:  666 685 98 1117 384 89 1150 389 155 55 148 64 
H-negative risk:  685 666 1150 1117 389 384 89 98 148 155 64 55 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 72 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
167 
disease_progression 
H-positive risk:  669 683 99 1109 386 89 1148 395 155 55 149 63 
H-negative risk:  683 669 1148 1109 395 386 89 99 149 155 63 55 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 71 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
168 
disease_progression 
H-positive risk:  677 685 98 1109 391 88 1135 399 153 56 145 64 
H-negative risk:  685 677 1135 1109 399 391 88 98 145 153 64 56 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 73 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
169 
disease_progression 
H-positive risk:  680 691 99 1103 384 89 1144 391 154 56 146 63 
H-negative risk:  691 680 1144 1103 391 384 89 99 146 154 63 56 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 74 17 

clinical_engagement 
diagnosis 
demography 
81 new agents 
170 
disease_progression 
H-positive risk:  677 682 99 1101 386 86 1143 400 158 58 141 69 
H-negative risk:  682 677 1143 1101 400 386 86 99 141 158 69 58 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 72 17 

clinical_engagement 
diagnosis 
demography 
78 new agents 
171 
disease_progression 
H-positive risk:  669 686 99 1096 389 87 1155 398 156 58 143 64 
H-negative risk:  686 669 1155 1096 398 389 87 99 143 156 64 58 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 74 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
172 
disease_progression 
H-positive risk:  673 691 101 1098 386 86 1159 386 153 57 146 64 
H-negative risk:  691 673 1159 1098 386 386 86 101 146 153 64 57 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 70 16 

clinical_engagement 
diagnosis 
demography 
89 new agents 
173 
disease_progression 
H-positive risk:  668 698 99 1094 386 87 1168 381 154 58 146 61 
H-negative risk:  698 668 1168 1094 381 386 87 99 146 154 61 58 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 71 15 

clinical_engagement 
diagnosis 
demography 
87 new agents 
174 
disease_progression 
H-positive risk:  675 705 101 1080 389 88 1172 377 151 57 144 61 
H-negative risk:  705 675 1172 1080 377 389 88 101 144 151 61 57 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 70 15 

clinical_engagement 
diagnosis 
demography 
60 new agents 
175 
disease_progression 
H-positive risk:  667 706 99 1079 392 90 1181 376 148 57 145 60 
H-negative risk:  706 667 1181 1079 376 392 90 99 145 148 60 57 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 71 15 

clinical_engagement 
diagnosis 
demography 
72 new agents 
176 
disease_progression 
H-positive risk:  668 707 99 1091 383 91 1167 388 147 57 142 60 
H-negative risk:  707 668 1167 1091 388 383 91 99 142 147 60 57 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 72 14 

clinical_engagement 
diagnosis 
demography 
72 new agents 
177 
disease_progression 
H-positive risk:  665 710 101 1095 382 91 1162 385 146 60 142 61 
H-negative risk:  710 665 1162 1095 385 382 91 101 142 146 61 60 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 75 15 

clinical_engagement 
diagnosis 
demography 
77 new agents 
178 
disease_progression 
H-positive risk:  664 703 99 1100 393 92 1159 383 146 60 138 63 
H-negative risk:  703 664 1159 1100 383 393 92 99 138 146 63 60 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 75 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
179 
disease_progression 
H-positive risk:  669 693 101 1104 395 92 1150 392 147 59 137 61 
H-negative risk:  693 669 1150 1104 392 395 92 101 137 147 61 59 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 80 15 

clinical_engagement 
diagnosis 
demography 
55 new agents 
180 
disease_progression 
H-positive risk:  667 693 101 1098 402 93 1152 391 142 62 139 60 
H-negative risk:  693 667 1152 1098 391 402 93 101 139 142 60 62 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 80 15 

clinical_engagement 
diagnosis 
demography 
73 new agents 
181 
disease_progression 
H-positive risk:  671 698 102 1088 404 92 1147 392 142 63 142 59 
H-negative risk:  698 671 1147 1088 392 404 92 102 142 142 59 63 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 83 15 

clinical_engagement 
diagnosis 
demography 
84 new agents 
182 
disease_progression 
H-positive risk:  679 693 106 1094 408 90 1141 383 143 64 140 59 
H-negative risk:  693 679 1141 1094 383 408 90 106 140 143 59 64 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 84 15 

clinical_engagement 
diagnosis 
demography 
72 new agents 
183 
disease_progression 
H-positive risk:  683 689 105 1098 405 89 1133 393 141 62 146 56 
H-negative risk:  689 683 1133 1098 393 405 89 105 146 141 56 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 84 15 

clinical_engagement 
diagnosis 
demography 
87 new agents 
184 
disease_progression 
H-positive risk:  688 691 103 1091 397 87 1143 395 140 59 149 57 
H-negative risk:  691 688 1143 1091 395 397 87 103 149 140 57 59 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 84 16 

clinical_engagement 
diagnosis 
demography 
83 new agents 
185 
disease_progression 
H-positive risk:  689 697 107 1084 390 87 1137 406 140 60 147 56 
H-negative risk:  697 689 1137 1084 406 390 87 107 147 140 56 60 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 83 15 

clinical_engagement 
diagnosis 
demography 
73 new agents 
186 
disease_progression 
H-positive risk:  685 689 104 1097 389 87 1135 410 140 58 152 54 
H-negative risk:  689 685 1135 1097 410 389 87 104 152 140 54 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 84 15 

clinical_engagement 
diagnosis 
demography 
72 new agents 
187 
disease_progression 
H-positive risk:  681 687 104 1098 391 89 1139 411 142 58 148 52 
H-negative risk:  687 681 1139 1098 411 391 89 104 148 142 52 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 83 16 

clinical_engagement 
diagnosis 
demography 
61 new agents 
188 
disease_progression 
H-positive risk:  686 685 102 1100 392 91 1132 413 141 58 149 51 
H-negative risk:  685 686 1132 1100 413 392 91 102 149 141 51 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 83 16 

clinical_engagement 
diagnosis 
demography 
76 new agents 
189 
disease_progression 
H-positive risk:  689 685 102 1105 390 93 1137 408 139 57 146 49 
H-negative risk:  685 689 1137 1105 408 390 93 102 146 139 49 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 80 16 

clinical_engagement 
diagnosis 
demography 
69 new agents 
190 
disease_progression 
H-positive risk:  693 684 103 1091 389 91 1147 405 143 55 146 53 
H-negative risk:  684 693 1147 1091 405 389 91 103 146 143 53 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 81 16 

clinical_engagement 
diagnosis 
demography 
64 new agents 
191 
disease_progression 
H-positive risk:  691 683 103 1093 397 91 1141 407 141 56 140 57 
H-negative risk:  683 691 1141 1093 407 397 91 103 140 141 57 56 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 81 18 

clinical_engagement 
diagnosis 
demography 
55 new agents 
192 
disease_progression 
H-positive risk:  692 683 102 1087 401 92 1140 408 141 52 145 57 
H-negative risk:  683 692 1140 1087 408 401 92 102 145 141 57 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
193 
disease_progression 
H-positive risk:  692 677 105 1091 398 91 1143 409 142 52 145 55 
H-negative risk:  677 692 1143 1091 409 398 91 105 145 142 55 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
91 new agents 
194 
disease_progression 
H-positive risk:  688 676 101 1084 410 91 1138 426 141 49 140 56 
H-negative risk:  676 688 1138 1084 426 410 91 101 140 141 56 49 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 88 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
195 
disease_progression 
H-positive risk:  692 676 101 1079 411 91 1131 425 144 51 142 57 
H-negative risk:  676 692 1131 1079 425 411 91 101 142 144 57 51 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
85 new agents 
196 
disease_progression 
H-positive risk:  689 675 100 1085 415 94 1129 422 146 46 144 55 
H-negative risk:  675 689 1129 1085 422 415 94 100 144 146 55 46 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
197 
disease_progression 
H-positive risk:  683 669 100 1097 409 92 1132 421 147 48 149 53 
H-negative risk:  669 683 1132 1097 421 409 92 100 149 147 53 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 86 17 

clinical_engagement 
diagnosis 
demography 
74 new agents 
198 
disease_progression 
H-positive risk:  675 666 100 1106 412 94 1131 423 142 46 149 56 
H-negative risk:  666 675 1131 1106 423 412 94 100 149 142 56 46 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 83 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
199 
disease_progression 
H-positive risk:  674 669 100 1103 418 94 1137 413 140 46 150 56 
H-negative risk:  669 674 1137 1103 413 418 94 100 150 140 56 46 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
68 new agents 
200 
disease_progression 
H-positive risk:  676 671 101 1102 416 92 1127 420 144 46 150 55 
H-negative risk:  671 676 1127 1102 420 416 92 101 150 144 55 46 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 79 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
201 
disease_progression 
H-positive risk:  673 670 103 1103 417 88 1132 422 147 46 147 52 
H-negative risk:  670 673 1132 1103 422 417 88 103 147 147 52 46 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 78 16 

clinical_engagement 
diagnosis 
demography 
77 new agents 
202 
disease_progression 
H-positive risk:  671 667 103 1103 420 89 1138 415 150 46 146 52 
H-negative risk:  667 671 1138 1103 415 420 89 103 146 150 52 46 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
203 
disease_progression 
H-positive risk:  664 664 104 1104 424 87 1145 409 153 45 149 52 
H-negative risk:  664 664 1145 1104 409 424 87 104 149 153 52 45 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
204 
disease_progression 
H-positive risk:  669 664 102 1102 420 86 1146 407 156 46 150 52 
H-negative risk:  664 669 1146 1102 407 420 86 102 150 156 52 46 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
205 
disease_progression 
H-positive risk:  661 672 103 1105 422 86 1141 413 153 46 149 49 
H-negative risk:  672 661 1141 1105 413 422 86 103 149 153 49 46 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
206 
disease_progression 
H-positive risk:  661 684 102 1101 433 85 1126 417 153 45 143 50 
H-negative risk:  684 661 1126 1101 417 433 85 102 143 153 50 45 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
207 
disease_progression 
H-positive risk:  659 689 102 1102 433 82 1114 424 154 46 144 51 
H-negative risk:  689 659 1114 1102 424 433 82 102 144 154 51 46 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
208 
disease_progression 
H-positive risk:  654 690 103 1111 431 87 1112 421 150 45 146 50 
H-negative risk:  690 654 1112 1111 421 431 87 103 146 150 50 45 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
76 new agents 
209 
disease_progression 
H-positive risk:  650 686 100 1121 438 89 1111 414 147 45 148 51 
H-negative risk:  686 650 1111 1121 414 438 89 100 148 147 51 45 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 77 27 

clinical_engagement 
diagnosis 
demography 
83 new agents 
210 
disease_progression 
H-positive risk:  644 695 102 1131 421 89 1112 411 148 48 145 54 
H-negative risk:  695 644 1112 1131 411 421 89 102 145 148 54 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
211 
disease_progression 
H-positive risk:  648 701 106 1132 406 89 1108 415 150 48 145 52 
H-negative risk:  701 648 1108 1132 415 406 89 106 145 150 52 48 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
212 
disease_progression 
H-positive risk:  655 691 106 1144 403 89 1105 411 151 51 145 49 
H-negative risk:  691 655 1105 1144 411 403 89 106 145 151 49 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
213 
disease_progression 
H-positive risk:  653 683 104 1147 411 88 1109 407 151 52 150 45 
H-negative risk:  683 653 1109 1147 407 411 88 104 150 151 45 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
214 
disease_progression 
H-positive risk:  645 687 103 1155 402 91 1118 403 152 49 151 44 
H-negative risk:  687 645 1118 1155 403 402 91 103 151 152 44 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
61 new agents 
215 
disease_progression 
H-positive risk:  642 679 98 1166 399 92 1115 407 151 50 156 45 
H-negative risk:  679 642 1115 1166 407 399 92 98 156 151 45 50 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
216 
disease_progression 
H-positive risk:  642 679 98 1167 400 93 1114 407 149 49 155 47 
H-negative risk:  679 642 1114 1167 407 400 93 98 155 149 47 49 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
217 
disease_progression 
H-positive risk:  645 675 94 1156 417 94 1109 415 145 50 155 45 
H-negative risk:  675 645 1109 1156 415 417 94 94 155 145 45 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
76 new agents 
218 
disease_progression 
H-positive risk:  649 672 95 1162 415 92 1106 409 149 48 158 45 
H-negative risk:  672 649 1106 1162 409 415 92 95 158 149 45 48 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
219 
disease_progression 
H-positive risk:  652 657 93 1155 415 97 1115 409 149 50 160 48 
H-negative risk:  657 652 1115 1155 409 415 97 93 160 149 48 50 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 80 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
220 
disease_progression 
H-positive risk:  649 651 94 1156 410 97 1123 412 151 50 157 50 
H-negative risk:  651 649 1123 1156 412 410 97 94 157 151 50 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
85 new agents 
221 
disease_progression 
H-positive risk:  657 659 95 1153 399 100 1117 409 150 53 156 52 
H-negative risk:  659 657 1117 1153 409 399 100 95 156 150 52 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
222 
disease_progression 
H-positive risk:  652 648 95 1158 406 100 1128 402 148 54 156 53 
H-negative risk:  648 652 1128 1158 402 406 100 95 156 148 53 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
223 
disease_progression 
H-positive risk:  652 649 97 1167 414 102 1118 397 145 54 155 50 
H-negative risk:  649 652 1118 1167 397 414 102 97 155 145 50 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
224 
disease_progression 
H-positive risk:  652 648 95 1161 417 103 1112 405 145 56 157 49 
H-negative risk:  648 652 1112 1161 405 417 103 95 157 145 49 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
225 
disease_progression 
H-positive risk:  663 648 97 1158 407 101 1118 405 145 55 156 47 
H-negative risk:  648 663 1118 1158 405 407 101 97 156 145 47 55 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
97 new agents 
226 
disease_progression 
H-positive risk:  670 660 99 1154 398 103 1109 402 148 54 153 50 
H-negative risk:  660 670 1109 1154 402 398 103 99 153 148 50 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
227 
disease_progression 
H-positive risk:  670 659 102 1153 400 100 1105 406 149 54 154 48 
H-negative risk:  659 670 1105 1153 406 400 100 102 154 149 48 54 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
228 
disease_progression 
H-positive risk:  665 668 103 1154 400 101 1106 403 148 52 152 48 
H-negative risk:  668 665 1106 1154 403 400 101 103 152 148 48 52 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
229 
disease_progression 
H-positive risk:  668 665 101 1149 401 103 1101 411 146 54 152 49 
H-negative risk:  665 668 1101 1149 411 401 103 101 152 146 49 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
67 new agents 
230 
disease_progression 
H-positive risk:  673 657 102 1157 408 102 1098 405 149 54 151 44 
H-negative risk:  657 673 1098 1157 405 408 102 102 151 149 44 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
84 new agents 
231 
disease_progression 
H-positive risk:  672 655 101 1160 405 103 1100 407 146 56 152 43 
H-negative risk:  655 672 1100 1160 407 405 103 101 152 146 43 56 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 95 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
232 
disease_progression 
H-positive risk:  677 646 102 1160 416 103 1099 402 148 55 148 44 
H-negative risk:  646 677 1099 1160 402 416 103 102 148 148 44 55 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 92 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
233 
disease_progression 
H-positive risk:  677 646 103 1147 421 105 1094 411 149 53 149 45 
H-negative risk:  646 677 1094 1147 411 421 105 103 149 149 45 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 90 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
234 
disease_progression 
H-positive risk:  673 641 106 1151 414 102 1102 412 152 54 150 43 
H-negative risk:  641 673 1102 1151 412 414 102 106 150 152 43 54 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
235 
disease_progression 
H-positive risk:  673 643 106 1137 420 106 1104 417 152 52 150 40 
H-negative risk:  643 673 1104 1137 417 420 106 106 150 152 40 52 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 93 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
236 
disease_progression 
H-positive risk:  677 642 106 1135 424 105 1101 413 156 53 149 39 
H-negative risk:  642 677 1101 1135 413 424 105 106 149 156 39 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
91 new agents 
237 
disease_progression 
H-positive risk:  671 640 105 1149 417 106 1106 410 155 54 151 36 
H-negative risk:  640 671 1106 1149 410 417 106 105 151 155 36 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
238 
disease_progression 
H-positive risk:  670 640 107 1153 416 107 1103 415 155 51 146 37 
H-negative risk:  640 670 1103 1153 415 416 107 107 146 155 37 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 90 18 

clinical_engagement 
diagnosis 
demography 
59 new agents 
239 
disease_progression 
H-positive risk:  670 650 106 1149 418 106 1093 417 156 50 148 37 
H-negative risk:  650 670 1093 1149 417 418 106 106 148 156 37 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
240 
disease_progression 
H-positive risk:  665 655 106 1143 418 107 1087 426 159 51 145 38 
H-negative risk:  655 665 1087 1143 426 418 107 106 145 159 38 51 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
241 
disease_progression 
H-positive risk:  670 648 107 1136 431 109 1073 436 155 49 145 41 
H-negative risk:  648 670 1073 1136 436 431 109 107 145 155 41 49 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 94 17 

clinical_engagement 
diagnosis 
demography 
79 new agents 
242 
disease_progression 
H-positive risk:  662 649 109 1131 436 109 1081 429 157 49 146 42 
H-negative risk:  649 662 1081 1131 429 436 109 109 146 157 42 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 95 17 

clinical_engagement 
diagnosis 
demography 
77 new agents 
243 
disease_progression 
H-positive risk:  664 654 111 1123 440 105 1078 427 159 47 149 43 
H-negative risk:  654 664 1078 1123 427 440 105 111 149 159 43 47 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 95 16 

clinical_engagement 
diagnosis 
demography 
86 new agents 
244 
disease_progression 
H-positive risk:  660 662 114 1122 439 105 1068 431 161 47 147 44 
H-negative risk:  662 660 1068 1122 431 439 105 114 147 161 44 47 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 100 16 

clinical_engagement 
diagnosis 
demography 
70 new agents 
245 
disease_progression 
H-positive risk:  650 661 113 1130 436 108 1079 422 157 50 147 47 
H-negative risk:  661 650 1079 1130 422 436 108 113 147 157 47 50 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 100 16 

clinical_engagement 
diagnosis 
demography 
53 new agents 
246 
disease_progression 
H-positive risk:  650 655 110 1129 435 112 1080 428 155 50 147 49 
H-negative risk:  655 650 1080 1129 428 435 112 110 147 155 49 50 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 99 16 

clinical_engagement 
diagnosis 
demography 
90 new agents 
247 
disease_progression 
H-positive risk:  648 661 107 1118 439 111 1087 423 152 52 152 50 
H-negative risk:  661 648 1087 1118 423 439 111 107 152 152 50 52 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 102 15 

clinical_engagement 
diagnosis 
demography 
72 new agents 
248 
disease_progression 
H-positive risk:  643 665 107 1122 431 110 1079 429 151 57 155 51 
H-negative risk:  665 643 1079 1122 429 431 110 107 155 151 51 57 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 104 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
249 
disease_progression 
H-positive risk:  647 667 107 1126 425 108 1076 430 151 58 154 51 
H-negative risk:  667 647 1076 1126 430 425 108 107 154 151 51 58 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 101 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
250 
disease_progression 
H-positive risk:  658 671 104 1115 412 112 1069 435 151 62 159 52 
H-negative risk:  671 658 1069 1115 435 412 112 104 159 151 52 62 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 98 16 

clinical_engagement 
diagnosis 
demography 
88 new agents 
251 
disease_progression 
H-positive risk:  661 675 104 1103 417 114 1074 431 147 62 159 53 
H-negative risk:  675 661 1074 1103 431 417 114 104 159 147 53 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 96 14 

clinical_engagement 
diagnosis 
demography 
70 new agents 
252 
disease_progression 
H-positive risk:  662 672 102 1102 418 114 1067 434 151 65 160 53 
H-negative risk:  672 662 1067 1102 434 418 114 102 160 151 53 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 95 13 

clinical_engagement 
diagnosis 
demography 
81 new agents 
253 
disease_progression 
H-positive risk:  652 671 104 1097 422 117 1083 425 152 62 161 54 
H-negative risk:  671 652 1083 1097 425 422 117 104 161 152 54 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 91 14 

clinical_engagement 
diagnosis 
demography 
69 new agents 
254 
disease_progression 
H-positive risk:  642 668 106 1099 420 119 1094 425 150 62 159 56 
H-negative risk:  668 642 1094 1099 425 420 119 106 159 150 56 62 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 92 15 

clinical_engagement 
diagnosis 
demography 
60 new agents 
255 
disease_progression 
H-positive risk:  639 672 105 1097 419 119 1091 430 150 65 158 55 
H-negative risk:  672 639 1091 1097 430 419 119 105 158 150 55 65 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 94 15 

clinical_engagement 
diagnosis 
demography 
88 new agents 
256 
disease_progression 
H-positive risk:  636 680 104 1091 422 118 1092 428 151 61 159 58 
H-negative risk:  680 636 1092 1091 428 422 118 104 159 151 58 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 92 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
257 
disease_progression 
H-positive risk:  645 674 102 1094 420 115 1086 427 154 63 159 61 
H-negative risk:  674 645 1086 1094 427 420 115 102 159 154 61 63 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 89 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
258 
disease_progression 
H-positive risk:  638 676 103 1098 420 110 1092 428 158 62 158 57 
H-negative risk:  676 638 1092 1098 428 420 110 103 158 158 57 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
259 
disease_progression 
H-positive risk:  640 674 101 1094 422 110 1090 430 159 63 159 58 
H-negative risk:  674 640 1090 1094 430 422 110 101 159 159 58 63 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
85 new agents 
260 
disease_progression 
H-positive risk:  644 680 102 1087 421 110 1084 427 168 63 159 55 
H-negative risk:  680 644 1084 1087 427 421 110 102 159 168 55 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
261 
disease_progression 
H-positive risk:  647 681 98 1090 416 112 1086 427 168 63 159 53 
H-negative risk:  681 647 1086 1090 427 416 112 98 159 168 53 63 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
262 
disease_progression 
H-positive risk:  650 686 100 1095 409 111 1086 423 166 62 160 52 
H-negative risk:  686 650 1086 1095 423 409 111 100 160 166 52 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
263 
disease_progression 
H-positive risk:  653 688 105 1087 413 109 1079 426 170 59 159 52 
H-negative risk:  688 653 1079 1087 426 413 109 105 159 170 52 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
264 
disease_progression 
H-positive risk:  653 694 106 1085 417 110 1077 419 165 61 159 54 
H-negative risk:  694 653 1077 1085 419 417 110 106 159 165 54 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
265 
disease_progression 
H-positive risk:  656 696 107 1077 421 110 1074 419 167 61 158 54 
H-negative risk:  696 656 1074 1077 419 421 110 107 158 167 54 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
266 
disease_progression 
H-positive risk:  659 693 108 1086 416 110 1067 420 167 61 161 52 
H-negative risk:  693 659 1067 1086 420 416 110 108 161 167 52 61 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
83 new agents 
267 
disease_progression 
H-positive risk:  655 695 108 1088 413 107 1077 418 167 63 159 50 
H-negative risk:  695 655 1077 1088 418 413 107 108 159 167 50 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
268 
disease_progression 
H-positive risk:  657 692 107 1090 416 102 1072 424 170 62 158 50 
H-negative risk:  692 657 1072 1090 424 416 102 107 158 170 50 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
269 
disease_progression 
H-positive risk:  651 696 108 1083 416 106 1082 423 169 59 155 52 
H-negative risk:  696 651 1082 1083 423 416 106 108 155 169 52 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
270 
disease_progression 
H-positive risk:  659 698 111 1077 409 107 1078 429 170 58 154 50 
H-negative risk:  698 659 1078 1077 429 409 107 111 154 170 50 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
271 
disease_progression 
H-positive risk:  661 693 111 1081 407 105 1076 430 171 58 153 54 
H-negative risk:  693 661 1076 1081 430 407 105 111 153 171 54 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 81 17 

clinical_engagement 
diagnosis 
demography 
71 new agents 
272 
disease_progression 
H-positive risk:  663 683 110 1089 403 105 1075 434 170 61 154 53 
H-negative risk:  683 663 1075 1089 434 403 105 110 154 170 53 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 81 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
273 
disease_progression 
H-positive risk:  661 686 109 1079 411 107 1076 428 168 62 160 53 
H-negative risk:  686 661 1076 1079 428 411 107 109 160 168 53 62 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 82 16 

clinical_engagement 
diagnosis 
demography 
83 new agents 
274 
disease_progression 
H-positive risk:  655 687 108 1078 413 106 1081 431 168 62 160 51 
H-negative risk:  687 655 1081 1078 431 413 106 108 160 168 51 62 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 81 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
275 
disease_progression 
H-positive risk:  654 698 106 1076 414 105 1079 431 166 62 156 53 
H-negative risk:  698 654 1079 1076 431 414 105 106 156 166 53 62 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
52 new agents 
276 
disease_progression 
H-positive risk:  651 697 107 1077 414 105 1085 427 166 63 155 53 
H-negative risk:  697 651 1085 1077 427 414 105 107 155 166 53 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
277 
disease_progression 
H-positive risk:  651 700 109 1080 407 103 1086 431 168 60 154 51 
H-negative risk:  700 651 1086 1080 431 407 103 109 154 168 51 60 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
278 
disease_progression 
H-positive risk:  656 705 106 1073 417 104 1082 423 166 60 156 52 
H-negative risk:  705 656 1082 1073 423 417 104 106 156 166 52 60 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
279 
disease_progression 
H-positive risk:  655 704 104 1083 412 105 1077 429 164 57 156 54 
H-negative risk:  704 655 1077 1083 429 412 105 104 156 164 54 57 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
280 
disease_progression 
H-positive risk:  660 707 102 1082 408 105 1075 433 157 59 158 54 
H-negative risk:  707 660 1075 1082 433 408 105 102 158 157 54 59 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
281 
disease_progression 
H-positive risk:  661 701 103 1091 409 103 1070 431 159 57 158 57 
H-negative risk:  701 661 1070 1091 431 409 103 103 158 159 57 57 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
282 
disease_progression 
H-positive risk:  666 701 105 1087 412 105 1066 431 156 58 157 56 
H-negative risk:  701 666 1066 1087 431 412 105 105 157 156 56 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
283 
disease_progression 
H-positive risk:  670 696 104 1080 417 106 1063 430 155 62 161 56 
H-negative risk:  696 670 1063 1080 430 417 106 104 161 155 56 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 81 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
284 
disease_progression 
H-positive risk:  669 691 102 1075 421 107 1070 430 153 63 162 57 
H-negative risk:  691 669 1070 1075 430 421 107 102 162 153 57 63 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
285 
disease_progression 
H-positive risk:  662 689 100 1086 421 105 1073 432 151 60 164 57 
H-negative risk:  689 662 1073 1086 432 421 105 100 164 151 57 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
286 
disease_progression 
H-positive risk:  657 699 101 1083 419 102 1076 435 150 58 165 55 
H-negative risk:  699 657 1076 1083 435 419 102 101 165 150 55 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
54 new agents 
287 
disease_progression 
H-positive risk:  659 694 97 1083 423 104 1072 433 152 58 168 57 
H-negative risk:  694 659 1072 1083 433 423 104 97 168 152 57 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
288 
disease_progression 
H-positive risk:  659 691 97 1090 426 106 1069 432 152 55 167 56 
H-negative risk:  691 659 1069 1090 432 426 106 97 167 152 56 55 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
55 new agents 
289 
disease_progression 
H-positive risk:  657 698 97 1077 426 108 1071 435 152 55 167 57 
H-negative risk:  698 657 1071 1077 435 426 108 97 167 152 57 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
85 new agents 
290 
disease_progression 
H-positive risk:  665 694 96 1077 429 108 1086 415 153 55 166 56 
H-negative risk:  694 665 1086 1077 415 429 108 96 166 153 56 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
291 
disease_progression 
H-positive risk:  656 703 96 1075 428 106 1092 416 152 56 164 56 
H-negative risk:  703 656 1092 1075 416 428 106 96 164 152 56 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
292 
disease_progression 
H-positive risk:  664 699 96 1077 427 105 1090 408 152 58 168 56 
H-negative risk:  699 664 1090 1077 408 427 105 96 168 152 56 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
62 new agents 
293 
disease_progression 
H-positive risk:  665 697 98 1075 426 108 1086 410 152 61 169 53 
H-negative risk:  697 665 1086 1075 410 426 108 98 169 152 53 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
294 
disease_progression 
H-positive risk:  665 687 98 1096 413 107 1087 409 152 64 168 54 
H-negative risk:  687 665 1087 1096 409 413 107 98 168 152 54 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
99 new agents 
295 
disease_progression 
H-positive risk:  671 692 95 1099 412 110 1074 414 152 61 169 51 
H-negative risk:  692 671 1074 1099 414 412 110 95 169 152 51 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
296 
disease_progression 
H-positive risk:  667 684 95 1106 411 111 1076 415 149 63 168 55 
H-negative risk:  684 667 1076 1106 415 411 111 95 168 149 55 63 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
297 
disease_progression 
H-positive risk:  668 681 95 1115 413 112 1080 410 144 63 167 52 
H-negative risk:  681 668 1080 1115 410 413 112 95 167 144 52 63 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
298 
disease_progression 
H-positive risk:  674 674 97 1116 413 110 1081 413 143 64 163 52 
H-negative risk:  674 674 1081 1116 413 413 110 97 163 143 52 64 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
57 new agents 
299 
disease_progression 
H-positive risk:  671 673 97 1105 425 111 1084 415 139 64 164 52 
H-negative risk:  673 671 1084 1105 415 425 111 97 164 139 52 64 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
300 
disease_progression 
H-positive risk:  677 671 92 1102 435 109 1087 405 140 64 166 52 
H-negative risk:  671 677 1087 1102 405 435 109 92 166 140 52 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 85 17 

clinical_engagement 
diagnosis 
demography 
71 new agents 
301 
disease_progression 
H-positive risk:  675 677 96 1084 437 108 1096 401 146 64 162 54 
H-negative risk:  677 675 1096 1084 401 437 108 96 162 146 54 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
302 
disease_progression 
H-positive risk:  669 685 96 1065 443 108 1103 399 147 70 160 55 
H-negative risk:  685 669 1103 1065 399 443 108 96 160 147 55 70 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
303 
disease_progression 
H-positive risk:  672 690 94 1060 444 107 1096 396 153 71 162 55 
H-negative risk:  690 672 1096 1060 396 444 107 94 162 153 55 71 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 88 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
304 
disease_progression 
H-positive risk:  668 680 95 1058 454 109 1102 396 151 66 163 58 
H-negative risk:  680 668 1102 1058 396 454 109 95 163 151 58 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
85 new agents 
305 
disease_progression 
H-positive risk:  676 677 94 1052 456 113 1094 402 153 64 161 58 
H-negative risk:  677 676 1094 1052 402 456 113 94 161 153 58 64 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 92 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
306 
disease_progression 
H-positive risk:  675 685 97 1056 453 112 1084 402 154 62 161 59 
H-negative risk:  685 675 1084 1056 402 453 112 97 161 154 59 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 90 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
307 
disease_progression 
H-positive risk:  676 681 94 1067 450 113 1073 405 160 59 163 59 
H-negative risk:  681 676 1073 1067 405 450 113 94 163 160 59 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
308 
disease_progression 
H-positive risk:  682 689 92 1055 452 112 1074 406 163 58 159 58 
H-negative risk:  689 682 1074 1055 406 452 112 92 159 163 58 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
309 
disease_progression 
H-positive risk:  679 690 92 1052 451 115 1080 404 159 54 164 60 
H-negative risk:  690 679 1080 1052 404 451 115 92 164 159 60 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
310 
disease_progression 
H-positive risk:  686 694 93 1051 453 115 1068 405 156 53 166 60 
H-negative risk:  694 686 1068 1051 405 453 115 93 166 156 60 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
311 
disease_progression 
H-positive risk:  697 689 91 1050 462 114 1059 401 158 53 167 59 
H-negative risk:  689 697 1059 1050 401 462 114 91 167 158 59 53 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 86 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
312 
disease_progression 
H-positive risk:  699 687 91 1047 455 115 1068 399 158 51 169 61 
H-negative risk:  687 699 1068 1047 399 455 115 91 169 158 61 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
86 new agents 
313 
disease_progression 
H-positive risk:  709 690 88 1044 452 117 1070 392 160 52 165 61 
H-negative risk:  690 709 1070 1044 392 452 117 88 165 160 61 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
314 
disease_progression 
H-positive risk:  707 678 88 1048 452 118 1066 401 162 52 167 61 
H-negative risk:  678 707 1066 1048 401 452 118 88 167 162 61 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
315 
disease_progression 
H-positive risk:  707 674 94 1058 448 118 1064 392 162 55 164 64 
H-negative risk:  674 707 1064 1058 392 448 118 94 164 162 64 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
316 
disease_progression 
H-positive risk:  711 682 92 1041 451 120 1067 397 163 55 157 64 
H-negative risk:  682 711 1067 1041 397 451 120 92 157 163 64 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
100 new agents 
317 
disease_progression 
H-positive risk:  707 697 92 1046 441 119 1051 402 165 59 155 66 
H-negative risk:  697 707 1051 1046 402 441 119 92 155 165 66 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
318 
disease_progression 
H-positive risk:  709 688 91 1048 443 119 1049 406 163 59 160 65 
H-negative risk:  688 709 1049 1048 406 443 119 91 160 163 65 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
93 new agents 
319 
disease_progression 
H-positive risk:  715 696 90 1053 440 116 1039 405 166 55 161 64 
H-negative risk:  696 715 1039 1053 405 440 116 90 161 166 64 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
320 
disease_progression 
H-positive risk:  715 692 94 1063 433 114 1041 405 167 55 158 63 
H-negative risk:  692 715 1041 1063 405 433 114 94 158 167 63 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
321 
disease_progression 
H-positive risk:  717 689 93 1073 428 113 1045 400 167 56 156 63 
H-negative risk:  689 717 1045 1073 400 428 113 93 156 167 63 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 84 28 

clinical_engagement 
diagnosis 
demography 
82 new agents 
322 
disease_progression 
H-positive risk:  714 691 94 1075 431 113 1047 395 164 59 156 61 
H-negative risk:  691 714 1047 1075 395 431 113 94 156 164 61 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 82 30 

clinical_engagement 
diagnosis 
demography 
87 new agents 
323 
disease_progression 
H-positive risk:  713 695 94 1072 427 114 1057 391 164 59 152 62 
H-negative risk:  695 713 1057 1072 391 427 114 94 152 164 62 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 79 28 

clinical_engagement 
diagnosis 
demography 
68 new agents 
324 
disease_progression 
H-positive risk:  708 699 95 1070 427 110 1060 393 163 57 159 59 
H-negative risk:  699 708 1060 1070 393 427 110 95 159 163 59 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 80 27 

clinical_engagement 
diagnosis 
demography 
88 new agents 
325 
disease_progression 
H-positive risk:  705 693 96 1076 425 111 1055 395 167 57 160 60 
H-negative risk:  693 705 1055 1076 395 425 111 96 160 167 60 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
326 
disease_progression 
H-positive risk:  705 690 95 1077 424 111 1054 395 165 60 165 59 
H-negative risk:  690 705 1054 1077 395 424 111 95 165 165 59 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
56 new agents 
327 
disease_progression 
H-positive risk:  705 683 95 1085 413 109 1060 401 165 61 160 63 
H-negative risk:  683 705 1060 1085 401 413 109 95 160 165 63 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 75 29 

clinical_engagement 
diagnosis 
demography 
74 new agents 
328 
disease_progression 
H-positive risk:  702 678 93 1091 408 109 1064 405 164 60 166 60 
H-negative risk:  678 702 1064 1091 405 408 109 93 166 164 60 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 73 29 

clinical_engagement 
diagnosis 
demography 
89 new agents 
329 
disease_progression 
H-positive risk:  698 679 94 1095 412 107 1059 402 164 62 166 62 
H-negative risk:  679 698 1059 1095 402 412 107 94 166 164 62 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 72 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
330 
disease_progression 
H-positive risk:  705 687 92 1096 409 108 1055 398 161 62 165 62 
H-negative risk:  687 705 1055 1096 398 409 108 92 165 161 62 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 71 28 

clinical_engagement 
diagnosis 
demography 
63 new agents 
331 
disease_progression 
H-positive risk:  712 681 88 1099 407 106 1056 401 163 66 164 57 
H-negative risk:  681 712 1056 1099 401 407 106 88 164 163 57 66 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 72 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
332 
disease_progression 
H-positive risk:  705 685 87 1099 414 104 1067 394 164 65 164 52 
H-negative risk:  685 705 1067 1099 394 414 104 87 164 164 52 65 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 73 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
333 
disease_progression 
H-positive risk:  694 682 88 1105 414 106 1073 393 164 64 166 51 
H-negative risk:  682 694 1073 1105 393 414 106 88 166 164 51 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 73 31 

clinical_engagement 
diagnosis 
demography 
70 new agents 
334 
disease_progression 
H-positive risk:  693 675 88 1105 416 101 1081 392 167 65 166 51 
H-negative risk:  675 693 1081 1105 392 416 101 88 166 167 51 65 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 72 30 

clinical_engagement 
diagnosis 
demography 
68 new agents 
335 
disease_progression 
H-positive risk:  686 687 85 1109 410 105 1080 391 168 63 163 53 
H-negative risk:  687 686 1080 1109 391 410 105 85 163 168 53 63 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 72 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
336 
disease_progression 
H-positive risk:  689 688 87 1112 402 107 1082 383 168 63 165 54 
H-negative risk:  688 689 1082 1112 383 402 107 87 165 168 54 63 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 72 28 

clinical_engagement 
diagnosis 
demography 
62 new agents 
337 
disease_progression 
H-positive risk:  685 684 86 1126 401 106 1075 389 169 64 164 51 
H-negative risk:  684 685 1075 1126 389 401 106 86 164 169 51 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 73 29 

clinical_engagement 
diagnosis 
demography 
73 new agents 
338 
disease_progression 
H-positive risk:  691 681 85 1124 397 105 1079 384 167 67 170 50 
H-negative risk:  681 691 1079 1124 384 397 105 85 170 167 50 67 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 69 29 

clinical_engagement 
diagnosis 
demography 
87 new agents 
339 
disease_progression 
H-positive risk:  706 687 82 1120 390 104 1077 383 166 65 170 50 
H-negative risk:  687 706 1077 1120 383 390 104 82 170 166 50 65 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 67 30 

clinical_engagement 
diagnosis 
demography 
72 new agents 
340 
disease_progression 
H-positive risk:  707 684 85 1124 393 105 1076 386 166 57 166 51 
H-negative risk:  684 707 1076 1124 386 393 105 85 166 166 51 57 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 68 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
341 
disease_progression 
H-positive risk:  711 687 87 1122 392 102 1074 383 167 59 163 53 
H-negative risk:  687 711 1074 1122 383 392 102 87 163 167 53 59 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 66 30 

clinical_engagement 
diagnosis 
demography 
76 new agents 
342 
disease_progression 
H-positive risk:  717 685 87 1122 391 105 1069 386 165 56 162 55 
H-negative risk:  685 717 1069 1122 386 391 105 87 162 165 55 56 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 69 27 

clinical_engagement 
diagnosis 
demography 
55 new agents 
343 
disease_progression 
H-positive risk:  715 684 86 1120 393 105 1072 387 167 52 161 58 
H-negative risk:  684 715 1072 1120 387 393 105 86 161 167 58 52 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 68 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
344 
disease_progression 
H-positive risk:  709 683 88 1122 387 104 1082 388 170 52 162 53 
H-negative risk:  683 709 1082 1122 388 387 104 88 162 170 53 52 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
345 
disease_progression 
H-positive risk:  710 680 86 1124 392 102 1085 383 174 51 160 53 
H-negative risk:  680 710 1085 1124 383 392 102 86 160 174 53 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 71 26 

clinical_engagement 
diagnosis 
demography 
96 new agents 
346 
disease_progression 
H-positive risk:  710 680 87 1126 393 103 1088 379 174 51 156 53 
H-negative risk:  680 710 1088 1126 379 393 103 87 156 174 53 51 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 70 29 

clinical_engagement 
diagnosis 
demography 
80 new agents 
347 
disease_progression 
H-positive risk:  711 688 86 1124 392 102 1084 381 173 50 158 51 
H-negative risk:  688 711 1084 1124 381 392 102 86 158 173 51 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 67 32 

clinical_engagement 
diagnosis 
demography 
95 new agents 
348 
disease_progression 
H-positive risk:  709 702 88 1122 387 103 1083 381 172 50 154 49 
H-negative risk:  702 709 1083 1122 381 387 103 88 154 172 49 50 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 68 32 

clinical_engagement 
diagnosis 
demography 
69 new agents 
349 
disease_progression 
H-positive risk:  702 703 86 1123 389 104 1076 391 173 49 156 48 
H-negative risk:  703 702 1076 1123 391 389 104 86 156 173 48 49 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 68 32 

clinical_engagement 
diagnosis 
demography 
81 new agents 
350 
disease_progression 
H-positive risk:  700 708 89 1107 394 104 1082 389 168 53 157 49 
H-negative risk:  708 700 1082 1107 389 394 104 89 157 168 49 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 68 33 

clinical_engagement 
diagnosis 
demography 
76 new agents 
351 
disease_progression 
H-positive risk:  705 711 87 1110 391 103 1087 388 166 51 151 50 
H-negative risk:  711 705 1087 1110 388 391 103 87 151 166 50 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 66 32 

clinical_engagement 
diagnosis 
demography 
70 new agents 
352 
disease_progression 
H-positive risk:  701 713 86 1105 395 100 1089 393 164 52 151 51 
H-negative risk:  713 701 1089 1105 393 395 100 86 151 164 51 52 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 64 32 

clinical_engagement 
diagnosis 
demography 
83 new agents 
353 
disease_progression 
H-positive risk:  694 716 84 1103 396 97 1092 401 165 51 151 50 
H-negative risk:  716 694 1092 1103 401 396 97 84 151 165 50 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 65 32 

clinical_engagement 
diagnosis 
demography 
71 new agents 
354 
disease_progression 
H-positive risk:  679 716 84 1107 401 97 1088 414 162 51 152 49 
H-negative risk:  716 679 1088 1107 414 401 97 84 152 162 49 51 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 64 32 

clinical_engagement 
diagnosis 
demography 
79 new agents 
355 
disease_progression 
H-positive risk:  687 711 84 1106 404 97 1088 405 160 55 152 51 
H-negative risk:  711 687 1088 1106 405 404 97 84 152 160 51 55 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 62 34 

clinical_engagement 
diagnosis 
demography 
68 new agents 
356 
disease_progression 
H-positive risk:  683 702 85 1104 400 99 1100 407 160 57 153 50 
H-negative risk:  702 683 1100 1104 407 400 99 85 153 160 50 57 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 64 34 

clinical_engagement 
diagnosis 
demography 
67 new agents 
357 
disease_progression 
H-positive risk:  683 706 84 1106 398 101 1093 412 156 58 153 50 
H-negative risk:  706 683 1093 1106 412 398 101 84 153 156 50 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 66 35 

clinical_engagement 
diagnosis 
demography 
78 new agents 
358 
disease_progression 
H-positive risk:  683 708 83 1102 395 98 1095 416 158 59 151 52 
H-negative risk:  708 683 1095 1102 416 395 98 83 151 158 52 59 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 67 33 

clinical_engagement 
diagnosis 
demography 
76 new agents 
359 
disease_progression 
H-positive risk:  686 709 87 1094 401 94 1095 411 160 61 147 55 
H-negative risk:  709 686 1095 1094 411 401 94 87 147 160 55 61 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 66 32 

clinical_engagement 
diagnosis 
demography 
84 new agents 
360 
disease_progression 
H-positive risk:  697 706 88 1098 391 93 1095 413 158 60 144 57 
H-negative risk:  706 697 1095 1098 413 391 93 88 144 158 57 60 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 66 32 

clinical_engagement 
diagnosis 
demography 
91 new agents 
Time difference of 19.1712 mins
This is task 12
date
